Media Statement - Global %

Statement on lanreotide in the U.S.

PARIS, FRANCE, 20 December 2021 – 6:00 PM CET – Ipsen has learned that Cipla Limited and its subsidiary Cipla

Statement on lanreotide European decentralised procedure

PARIS, FRANCE, 8 March 2021 – Ipsen has learned that Amdipharm Ltd, which is believed to be a subsidiary of

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.